Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2009;329:59–76. doi: 10.1007/978-3-540-70523-9_4

Measles Virus Glycoprotein Complex Assembly, Receptor Attachment, and Cell Entry

C K Navaratnarajah ‡, V H J Leonard ‡, R Cattaneo ‡,✉
Editors: Diane E Griffin*, Michael B A Oldstone6
PMCID: PMC7121846  PMID: 19198562

Abstract

Measles virus (MV) enters cells by membrane fusion at the cell surface at neutral pH. Two glycoproteins mediate this process: the hemagglutinin (H) and fusion (F) proteins. The H-protein binds to receptors, while the F-protein mediates fusion of the viral and cellular membranes. H naturally interacts with at least three different receptors. The wild-type virus primarily uses the signaling lymphocyte activation molecule (SLAM, CD150) expressed on certain lymphatic cells, while the vaccine strain has gained the ability to also use the ubiquitous membrane cofactor protein (MCP, CD46), a regulator of complement activation. Additionally, MV infects polarized epithelial cells through an unidentified receptor (EpR). The footprints of the three receptors on H have been characterized, and the focus of research is shifting to the characterization of receptor-specific conformational changes that occur in the H-protein dimer and how these are transmitted to the F-protein trimer. It was also shown that MV attachment and cell entry can be readily targeted to designated receptors by adding specificity determinants to the H-protein. These studies have contributed to our understanding of membrane fusion by the glycopro-tein complex of paramyxoviruses in general.

Keywords: Newcastle Disease Virus, Measle Virus, Cell Entry, Purine Nucleoside Phosphorylase, Fusion Activation

Contributor Information

Diane E. Griffin, Email: dgriffin@mail.jhmi.edu, Email: dgriffin@jhsph.edu

Michael B. A. Oldstone, Email: mbaobo@scripps.edu

R. Cattaneo, Email: Cattaneo.Roberto@mayo.edu

References

  1. Alkhatib G, Briedis DJ. The predicted primary structure of the measles virus hemagglutinin. Virology. 1986;150:479–490. doi: 10.1016/0042-6822(86)90312-0. [DOI] [PubMed] [Google Scholar]
  2. Armstrong MA, Fraser KB, Dermott E, Shirodaria PV. Immunoelectron microscopic studies on haemagglutinin and haemolysin of measles virus in infected HEp2 cells. J Gen Virol. 1982;59:187–192. doi: 10.1099/0022-1317-59-1-187. [DOI] [PubMed] [Google Scholar]
  3. Bartz R, Brinckmann U, Dunster LM, Rima B, ter Meulen V, Schaulies Schneider-J. Mapping amino acids of the measles virus hemagglutinin responsible for receptor (CD46) downregulation. Virology. 1996;224:334–337. doi: 10.1006/viro.1996.0538. [DOI] [PubMed] [Google Scholar]
  4. Bolt G, Pedersen IR. The role of subtilisin-like proprotein convertases for cleavage of the measles virus fusion glycoprotein in different cell types. Virology. 1998;252:387–398. doi: 10.1006/viro.1998.9464. [DOI] [PubMed] [Google Scholar]
  5. Bucheit AD, Kumar S, Grote DM, Lin Y, von Messling V, Cattaneo RB, Fielding AK. An oncolytic measles virus engineered to enter cells through the CD20 antigen. Mol Ther. 2003;7:62–72. doi: 10.1016/S1525-0016(02)00033-3. [DOI] [PubMed] [Google Scholar]
  6. Buchholz CJ, Schneider U, Devaux P, Gerlier D, Cattaneo R. Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J Virol. 1996;70:3716–3723. doi: 10.1128/jvi.70.6.3716-3723.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Buchholz CJ, Koller D, Devaux P, Mumenthaler C, Schneider-Schaulies J, Braun W, et al. Mapping of the primary binding site of measles virus to its receptor CD46. J Biol Chem. 1997;272:22072–22079. doi: 10.1074/jbc.272.35.22072. [DOI] [PubMed] [Google Scholar]
  8. Buckland R, Malvoisin E, Beauverger P, Wild F. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J Gen Virol. 1992;73:1703–1707. doi: 10.1099/0022-1317-73-7-1703. [DOI] [PubMed] [Google Scholar]
  9. Buechi M, Bachi T. Microscopy of internal structures of Sendai virus associated with the cytoplasmic surface of host membranes. Virology. 1982;120:349–359. doi: 10.1016/0042-6822(82)90036-8. [DOI] [PubMed] [Google Scholar]
  10. Casali P, Sissons JG, Fujinami RS, Oldstone MB. Purification of measles virus glycoproteins and their integration into artificial lipid membranes. J Gen Virol. 1981;54:161–171. doi: 10.1099/0022-1317-54-1-161. [DOI] [PubMed] [Google Scholar]
  11. Casasnovas JM, Larvie M, Stehle T. Crystal structure of two CD46 domains reveals an extended measles virus-binding surface. EMBO J. 1999;18:2911–2922. doi: 10.1093/emboj/18.11.2911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cathomen T, Mrkic B, Spehner D, Drillien R, Naef R, Pavlovic J, et al. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J. 1998;17:3899–3908. doi: 10.1093/emboj/17.14.3899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cattaneo R, Rose JK. Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol. 1993;67:1493–1502. doi: 10.1128/jvi.67.3.1493-1502.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cherry J (2003) Measles virus. In: Buck C, Demmler G, Kaplan S (eds) Textbook of pediatric infectious diseases. Elsevier, pp 2283–2304
  15. Cocks BG, Chang CC, Carballido JM, Yssel H, de Vries JE, Aversa G. A novel receptor involved in T-cell activation. Nature. 1995;376:260–263. doi: 10.1038/376260a0. [DOI] [PubMed] [Google Scholar]
  16. Colf LA, Juo ZS, Garcia KC. Structure of the measles virus hemagglutinin. Nat Struct Mol Biol. 2007;14:1227–1228. doi: 10.1038/nsmb1342. [DOI] [PubMed] [Google Scholar]
  17. Condack C, Grivel JC, Devaux P, Margolis L, Cattaneo R. Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J Infect Dis. 2007;196:541–549. doi: 10.1086/519689. [DOI] [PubMed] [Google Scholar]
  18. Corey EA, Iorio RM. Mutations in the stalk of the measles virus hemagglutinin protein decrease fusion but do not interfere with virus-specific interaction with the homologous fusion protein. J Virol. 2007;81:9900–9910. doi: 10.1128/JVI.00909-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Crennell S, Takimoto T, Portner A, Taylor G. Crystal structure of the multifunctional para-myxovirus hemagglutinin-neuraminidase. Nat Struct Biol. 2000;7:1068–1074. doi: 10.1038/81002. [DOI] [PubMed] [Google Scholar]
  20. de Swart RL, Ludlow M, de Witte L, Yanagi Y, van Amerongen G, McQuaid S, et al. Predominant infection of CD150 + lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog. 2007;3:1771–1781. doi: 10.1371/journal.ppat.0030178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Devaux P, Buchholz CJ, Schneider U, Escoffier C, Cattaneo R, Gerlier D. CD46 short consensus repeats III and IV enhance measles virus binding but impair soluble hemagglutinin binding. J Virol. 1997;71:4157–4160. doi: 10.1128/jvi.71.5.4157-4160.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain) Cell. 1993;75:295–305. doi: 10.1016/0092-8674(93)80071-L. [DOI] [PubMed] [Google Scholar]
  23. Erlenhoefer C, Wurzer WJ, Loffler S, Schneider-Schaulies S, ter Meulen V, Schneider-Schaulies J. CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J Virol. 2001;75:4499–4505. doi: 10.1128/JVI.75.10.4499-4505.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Fournier P, Brons NH, Berbers GA, Wiesmuller KH, Fleckenstein BT, Schneider F, et al. Antibodies to a new linear site at the topographical or functional interface between the hae-magglutinin and fusion proteins protect against measles encephalitis. J Gen Virol. 1997;78:1295–1302. doi: 10.1099/0022-1317-78-6-1295. [DOI] [PubMed] [Google Scholar]
  25. Funke S, Maisner A, Mühlebach MD, Koehl U, Grez M, Cattaneo R, et al. Targeted cell entry of lentiviral vectors. Mol Ther. 2008;16(8):1427–1436. doi: 10.1038/mt.2008.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Griffin DE. Measles virus. In: Knipe DM, Howley PM, editors. Fields' virology. Philadelphia: Lippincott Williams and Wilkins; 2007. pp. 1551–1585. [Google Scholar]
  27. Hallak LK, Merchan JR, Storgard CM, Loftus JC, Russell SJ. Targeted measles virus vector displaying Echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regression. Cancer Res. 2005;65:5292–5300. doi: 10.1158/0008-5472.CAN-04-2879. [DOI] [PubMed] [Google Scholar]
  28. Hammond AL, Plemper RK, Zhang J, Schneider U, Russell SJ, Cattaneo R. Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen. J Virol. 2001;75:2087–2096. doi: 10.1128/JVI.75.5.2087-2096.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hashiguchi T, Kajikawa M, Maita N, Takeda M, Kuroki K, Sasaki K, et al. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci U S A. 2007;104:19535–19540. doi: 10.1073/pnas.0707830104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hsu EC, Sarangi F, Iorio C, Sidhu MS, Udem SA, Dillehay DL, et al. A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol. 1998;72:2905–2916. doi: 10.1128/jvi.72.4.2905-2916.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hsu EC, Sabatinos S, Hoedemaeker FJ, Rose DR, Richardson CD. Use of site-specific mutagenesis and monoclonal antibodies to map regions of CD46 that interact with measles virus H protein. Virology. 1999;258:314–326. doi: 10.1006/viro.1999.9712. [DOI] [PubMed] [Google Scholar]
  32. Hsu EC, Iorio C, Sarangi F, Khine AA, Richardson CD. CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology. 2001;279:9–21. doi: 10.1006/viro.2000.0711. [DOI] [PubMed] [Google Scholar]
  33. Hu A, Cathomen T, Cattaneo R, Norrby E. Influence of N-linked oligosaccharide chains on the processing, cell surface expression and function of the measles virus fusion protein. J Gen Virol. 1995;76:705–710. doi: 10.1099/0022-1317-76-3-705. [DOI] [PubMed] [Google Scholar]
  34. Kielian M, Rey FA. Virus membrane-fusion proteins: more than one way to make a hairpin. Nat Rev Microbiol. 2006;4:67–76. doi: 10.1038/nrmicro1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Lamb RA. Paramyxovirus fusion: a hypothesis for changes. Virology. 1993;197:1–11. doi: 10.1006/viro.1993.1561. [DOI] [PubMed] [Google Scholar]
  36. Lamb RA, Parks GD. Paramyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott Williams and Wilkins; 2007. pp. 1449–1496. [Google Scholar]
  37. Lawrence MC, Borg NA, Streltsov VA, Pilling PA, Epa VC, Varghese JN, et al. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J Mol Biol. 2004;335:1343–1357. doi: 10.1016/j.jmb.2003.11.032. [DOI] [PubMed] [Google Scholar]
  38. Lecouturier V, Fayolle J, Caballero M, Carabana J, Celma ML, Fernandez-Munoz R, et al. Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. J Virol. 1996;70:4200–4204. doi: 10.1128/jvi.70.7.4200-4204.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Leonard VHJ, Sinn PL, Hodge G, Miest T, Devaux P, Oezguen N, et al. Epithelial cell receptor-blind measles virus remains virulent but cannot cross epithelia and is not shed. J Clin Invest. 2008;118(7):2448–2458. doi: 10.1172/JCI35454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Liu TC, Galanis E, Kirn D. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress. Nat Clin Pract Oncol. 2007;4:101–117. doi: 10.1038/ncponc0736. [DOI] [PubMed] [Google Scholar]
  41. Ludwig K, Schade B, Bottcher C, Korte T, Ohlwein N, Baljinnyam B, et al. Electron cryo-microscopy reveals different F1+F2 protein states in intact parainfluenza virions. J Virol. 2008;82:3775–3781. doi: 10.1128/JVI.02154-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Manchester M, Gairin JE, Patterson JB, Alvarez J, Liszewski MK, Eto DS, et al. Measles virus recognizes its receptor via two distinct binding domains within SCR1–2. Virology. 1997;233:174–184. doi: 10.1006/viro.1997.8581. [DOI] [PubMed] [Google Scholar]
  43. Masse N, Ainouze M, Neel B, Wild TF, Buckland R, Langedijk JP. Measles virus (MV) hemagglutinin: evidence that attachment sites for MV receptors SLAM and CD46 overlap on the globular head. J Virol. 2004;78:9051–9063. doi: 10.1128/JVI.78.17.9051-9063.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. McGinnes LW, Morrison TG. Inhibition of receptor binding stabilizes Newcastle disease virus HN and F protein-containing complexes. J Virol. 2006;80:2894–2903. doi: 10.1128/JVI.80.6.2894-2903.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Mühlebach MD, Leonard VHJ, Cattaneo R (2008) The measles virus fusion protein transmem-brane region controls formation of an active glycoprotein complex and fusion efficiency. J Virol (in press) [DOI] [PMC free article] [PubMed]
  46. Nakamura T, Peng KW, Vongpunsawad S, Harvey M, Mizuguchi H, Hayakawa T, et al. Antibody-targeted cell fusion. Nat Biotechnol. 2004;22:331–336. doi: 10.1038/nbt942. [DOI] [PubMed] [Google Scholar]
  47. Nakamura T, Peng KW, Harvey M, Greiner S, Lorimer IA, James CD, Russell SJ. Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol. 2005;23:209–214. doi: 10.1038/nbt1060. [DOI] [PubMed] [Google Scholar]
  48. Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol. 1993;67:6025–6032. doi: 10.1128/jvi.67.10.6025-6032.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Navaratnarajah CK, Vongpunsawad S, Oezguen N, Stehle T, Braun W, Hashiguchi T, et al. Dynamic Interaction of the measles virus hemagglutinin with its receptor signaling lym-phocytic activation molecule (SLAM, CD150) J Biol Chem. 2008;283:11763–11771. doi: 10.1074/jbc.M800896200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Ohno S, Seki F, Ono N, Yanagi Y. Histidine at position 61 and its adjacent amino acid residues are critical for the ability of SLAM (CD150) to act as a cellular receptor for measles virus. J Gen Virol. 2003;84:2381–2388. doi: 10.1099/vir.0.19248-0. [DOI] [PubMed] [Google Scholar]
  51. Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, Yanagi Y. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol. 2001a;75:4399–4401. doi: 10.1128/JVI.75.9.4399-4401.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Ono N, Tatsuo H, Tanaka K, Minagawa H, Yanagi Y. V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor. J Virol. 2001b;75:1594–1600. doi: 10.1128/JVI.75.4.1594-1600.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Panum P. Observations made during the epidemic of measles on the Faroe Islands in the year 1846. Med Classics. 1939;3:803–886. [Google Scholar]
  54. Peng KW, Donovan KA, Schneider U, Cattaneo R, Lust JA, Russell SJ. Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker. Blood. 2003;101:2557–2562. doi: 10.1182/blood-2002-07-2195. [DOI] [PubMed] [Google Scholar]
  55. Plemper RK, Hammond AL, Cattaneo R. Characterization of a region of the measles virus hemagglutinin sufficient for its dimerization. J Virol. 2000;74:6485–6493. doi: 10.1128/JVI.74.14.6485-6493.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Plemper RK, Hammond AL, Cattaneo R. Measles virus envelope glycoproteins hetero-oli-gomerize in the endoplasmic reticulum. J Biol Chem. 2001;276:44239–44246. doi: 10.1074/jbc.M105967200. [DOI] [PubMed] [Google Scholar]
  57. Plemper RK, Hammond AL, Gerlier D, Fielding AK, Cattaneo R. Strength of envelope protein interaction modulates cytopathicity of measles virus. J Virol. 2002;76:5051–5061. doi: 10.1128/JVI.76.10.5051-5061.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Rager M, Vongpunsawad S, Duprex WP, Cattaneo R. Polyploid measles virus with hexam-eric genome length. EMBO J. 2002;21:2364–2372. doi: 10.1093/emboj/21.10.2364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Richardson C, Hull D, Greer P, Hasel K, Berkovich A, Englund G, et al. The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses. Virology. 1986;155:508–523. doi: 10.1016/0042-6822(86)90212-6. [DOI] [PubMed] [Google Scholar]
  60. Schneider U, Bullough F, Vongpunsawad S, Russell SJ, Cattaneo R. Recombinant measles viruses efficiently entering cells through targeted receptors. J Virol. 2000;74:9928–9936. doi: 10.1128/JVI.74.21.9928-9936.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Schneider-Schaulies J, Schnorr JJ, Brinckmann U, Dunster LM, Baczko K, Liebert UG, et al. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci USA. 1995;92:3943–3947. doi: 10.1073/pnas.92.9.3943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Springfeld C, von Messling V, Frenzke M, Ungerechts G, Buchholz CJ, Cattaneo R. Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases. Cancer Res. 2006;66:7694–7700. doi: 10.1158/0008-5472.CAN-06-0538. [DOI] [PubMed] [Google Scholar]
  63. Tahara M, Takeda M, Shirogane Y, Hashiguchi T, Ohno S, Yanagi Y. Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J Virol. 2008;82:4630–4637. doi: 10.1128/JVI.02691-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature. 2000;406:893–897. doi: 10.1038/35022579. [DOI] [PubMed] [Google Scholar]
  65. Ungerechts G, Springfeld C, Frenzke ME, Lampe J, Johnston PB, Parker WB, et al. Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can syner-gize with fludarabine. Cancer Res. 2007a;67:10939–10947. doi: 10.1158/0008-5472.CAN-07-1252. [DOI] [PubMed] [Google Scholar]
  66. Ungerechts G, Springfeld C, Frenzke ME, Lampe J, Parker WB, Sorscher EJ, Cattaneo R. An immunocompetent murine model for oncolysis with an armed and targeted measles virus. Mol Ther. 2007b;15:1991–1997. doi: 10.1038/sj.mt.6300291. [DOI] [PubMed] [Google Scholar]
  67. von Messling V, Svitek N, Cattaneo R. Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus. J Virol. 2006;80:6084–6092. doi: 10.1128/JVI.00357-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Vongpunsawad S, Oezgun N, Braun W, Cattaneo R. Selectively receptor-blind measles viruses: identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol. 2004;78:302–313. doi: 10.1128/JVI.78.1.302-313.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Watanabe M, Hirano A, Stenglein S, Nelson J, Thomas G, Wong TC. Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus. J Virol. 1995;69:3206–3210. doi: 10.1128/jvi.69.5.3206-3210.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Wild TF, Malvoisin E, Buckland R. Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. J Gen Virol. 1991;72:439–442. doi: 10.1099/0022-1317-72-2-439. [DOI] [PubMed] [Google Scholar]
  71. Yanagi Y, Takeda M, Ohno S. Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol. 2006;87:2767–2779. doi: 10.1099/vir.0.82221-0. [DOI] [PubMed] [Google Scholar]
  72. Yin HS, Wen X, Paterson RG, Lamb RA, Jardetzky TS. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature. 2006;439:38–44. doi: 10.1038/nature04322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Yuan P, Thompson TB, Wurzburg BA, Paterson RG, Lamb RA, Jardetzky TS. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure. 2005;13:803–815. doi: 10.1016/j.str.2005.02.019. [DOI] [PubMed] [Google Scholar]

Articles from Measles are provided here courtesy of Nature Publishing Group

RESOURCES